| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Merck & Co., Inc. (MRK) has 26 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. MRK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 456.9K | $51.84M | - | |
| VP | 197.9K | $22.45M | - | |
| Dir | 108.3K | $12.29M | - | |
| Pres | 96.8K | $10.98M | - | |
| CFO | 94.2K | $10.69M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2022 | Karachun Rita A | Sr. VP Fince-global Controller | Sale+OE | 31,997 | $100.34 | $3,210,684.57 | -43.8% | +6.8% | +4.8% | |
| Nov 9, 2021 | Frazier Kenneth C | Executive Chair | Sale+OE | 663,881 | $82.26 | $54,611,361.66 | -35.6% | -5.3% | +27.1% | |
| Nov 4, 2021 | Litchfield Caroline | EVP &CFO | Sale+OE | 18,335 | $91.00 | $1,668,503.34 | -43.2% | -8.6% | +13.4% | |
| Nov 4, 2021 | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sale+OE | 29,782 | $90.40 | $2,692,298.76 | -20.3% | -8.6% | +13.4% | |
| Nov 3, 2021 | Karachun Rita A | Sr. VP Fince-global Controller | Sale+OE | 25,000 | $88.45 | $2,211,215.00 | -41.1% | -6.7% | +15.3% | |
| Nov 1, 2021 | Gerberding Julie L. | EVP, Chief Patient Officer | Sale+OE | 96,270 | $87.91 | $8,462,681.74 | -71.1% | -6.4% | +17.6% | |
| Nov 1, 2021 | Clyburn Frank | EVP &Pres ? Human Health | Sale+OE | 39,762 | $87.87 | $3,493,878.99 | -29.1% | -6.4% | +17.6% | |
| Oct 29, 2021 | Chattopadhyay Sanat | Exe V-p &Pres. Mmd | Sale+OE | 24,619 | $87.32 | $2,149,731.08 | -20.9% | -7.6% | +18.5% | |
| Oct 29, 2021 | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sale+OE | 135,405 | $87.56 | $11,856,264.91 | -53.7% | -7.6% | +18.5% | |
| May 10, 2021 | Clyburn Frank | EVP &Pres ? Human Health | Sale+OE | 19,324 | $78.32 | $1,513,440.22 | -17.0% | -2.8% | +16.4% |